Knight Therapeutics Inc. (TSE:GUD – Get Free Report)’s share price shot up 0.9% during trading on Monday . As a group, equities research analysts expect that Knight Therapeutics Inc. will post 0.1009486 EPS for the current fiscal year. Knight Therapeutics Company Profile(Get Free Report)Knight Therapeutics Inc, headquartered in Montreal, Canada, is a pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. For more information about Knight Therapeutics Inc, please visit the company’s web site at www.knighttx.com or www.sedarplus.ca. Recommended StoriesReceive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.